glp 1 liver enzymes Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Disease—Current Background, Hopes, and Perspectives Glucagon-like Peptide-1 Receptor Agonists (GLP-1
Description
2025 ASCO Annual Meeting
Katsurada K, Yada T (2016) Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist
Studies with liraglutide have shown mixed results, with some suggesting potential benefits alongside modest motor effects, though robust evidence for cognitive improvements is currently lacking
In the 1990s, scientists zeroed in on its secret weapon: exendin-4, a peptide lurking in its venomous saliva
BMC Immunol
Anesthesia and analgesia 2026;142(4):639
